Oxyguanidines. Part 2: Discovery of a novel orally active thrombin ...
Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis. ...
http://www.ncbi.nlm.nih.gov/pubmed/15203151...
|
Oxyguanidines. Part 2: Discovery of a novel orally...[Bioorg Med ...
PubMed is a service of the US National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for ...
http://view.ncbi.nlm.nih.gov/pubmed/15203151...
|
Oxyguanidines: application to non-peptidic phenyl-...[Bioorg Med ...
We report here a novel series non-peptidic phenyl-based, highly potent, highly selective and orally bioavailable thrombin inhibitors using oxyguanidines as ...
http://www.ncbi.nlm.nih.gov/pubmed/12668020...
|
American Chemical Society – 234th National Meeting Targeting ...
cyclic oxyguanidines were also synthesized, but displayed. no activity against iNOS. AZ-10397767 – a CXCR2/CCR2b antagonist. from AstraZeneca ...
http://www.biomedcentral.com/content/pdf/cd-832872.pdf...
|
Benzylamine-based selective and orally bioavailabl...[Bioorg Med ...
1999]; Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors. ... 2003]; Oxyguanidines. Part 2: Discovery of a novel orally active ...
http://www.ncbi.nlm.nih.gov/pubmed/9873581...
|
BioPortfolio - 3-Dimensional Pharmaceuticals Incorporated - Profile
Sep 6;14(17):4553-5. (DOI Direct Link). • Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based ...
http://www.bioportfolio.com/biocorporate/4-3-Dimensional+Pha...
|
Studies towards the identification of potent, sele...[Bioorg Med ...
2003]; Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesis. ...
http://www.ncbi.nlm.nih.gov/pubmed/10201839...
|
Paper alert
Oxyguanidines: Application to non-peptidic phenyl-. based thrombin inhibitors. Tomczuk B, Lu T, Soll RM, Fedde C, Wang A, Murphy L,. Crysler C, Dasgupta M, ...
http://www.biomedcentral.com/content/pdf/cd-498573.pdf...
|